Search results
Canes land four-star receiver. Where Miami’s 2025 offensive class now stands
Miami Herald via Yahoo Canada Sports· 4 days agoFSU, Penn State and Wisconsin are among his other offers. He led Milton High to an...star interior...
Faye Dunaway - Actress
TV Insider· 4 days agoAn icy, elegant blonde with a knack for playing complex and strong-willed female leads, Academy Award winner Faye Dunaway was an enormously popular...
Why Alabama coach Kalen DeBoer just might have what it takes to follow legend Nick Saban
CBS Sports· 5 days agoAlabama has not worn down its new coach. "I remember after A-Day (Alabama's spring game), he's in...
Community gathers for vigil honoring three football players killed in crash
WJLA· 5 days agoOn Friday night, loved ones gathered for a vigil to honor three football players from Maryland who...
Penn State’s general support funding flat in PA’s budget but a new funding model is coming
State College Centre Daily Times via Yahoo Canada News· 5 days agoA council will develop recommendations for a process that utilizes performance-based metrics to...
Q&A: Finding novel therapies for childhood cancer
Medical Xpress· 5 days agoSince the first time she treated a child with neuroblastoma, Giselle Saulnier Sholler wanted to do the impossible for her patients. Neuroblastoma is...
Alternative understanding of brain leads to new treatments for stroke patients
Medical Xpress· 5 days agoNearly 30 years ago, though, a researcher at Penn State proposed the complementary dominance...
Don't blame mental illness for shootings. Short fuses, easy access to guns form deadly mix
Chicago Sun-Times· 6 days agoGun-related shootings in the U.S. are astoundingly commonplace, whether premeditated or in the heat...
Who are the 2025 NFL Draft's top transfer prospects?
New York Times· 6 days agoThree years ago, we wondered if the newly unrestricted NCAA transfer portal would impact the first round of the NFL Draft. Last year, we wondered when —...
Senhwa Biosciences Announces IND Submission to US FDA for the Phase I/II study of Silmitasertib...
StreetInsider· 6 days agoSenhwa Biosciences, Inc. (TPEx: 6492), announced IND Submission to US FDA for the Phase I/II study of Silmitasertib (CX-4945) in combination with chemotherapy in children and young adults with ...